Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
about
Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.Current status of antiviral therapy for hepatitis BMolecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriersGenotype A2/adw2 Strain of Hepatitis B Virus in Turkey.Antiviral therapies: focus on hepatitis B reverse transcriptaseUse of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants.Viral resistance in hepatitis B: prevalence and management.Molecular diagnosis of entecavir resistanceValidation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.Correlation between HBsAg quantitation and HBV DNA in HBeAg-negative HBV/D patients.Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.Hepatitis B virus genotypes, subgenotypes, precore, and basal core promoter mutations in the two largest provinces of Pakistan.Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection.
P2860
Q33285254-EE1C636A-35DE-40D1-919F-AAAD55AD1453Q34408879-5397D773-6E81-4434-8E3F-861677C8132BQ35608358-54E2D8C2-FA77-40E9-BFA9-EB105184FAF6Q35731124-7AD96AA8-D0C8-4DF3-AA9E-2D5B2817AC75Q36467514-4FC3DA0B-1893-4E93-8BC0-9E06BDAAD8C6Q37099761-3D1BB1F3-F65D-4AE5-AC7F-9CE0790A361DQ37376530-41902BBB-DFF3-44FB-876A-69A5EDBBC618Q39429039-BB669C11-FE99-408D-B27A-756545AB71FFQ40789723-DD1E6589-A4CA-4B5C-88FA-523FA57B6023Q42124703-A755517F-E23A-4671-9CA0-E1CB564BFF86Q42177495-3AEEB66F-FC91-40E6-B4D9-0DF6BA972C1EQ42407103-C1054267-0E7A-4FA6-9BB0-F45797C91FC8Q43141117-A9A0DC49-7CEC-4982-8518-F601539714C4Q45385329-FCD19D57-8AFC-4B13-8609-80E5A52DCBE6Q46044243-7E5AD9E6-CB35-4AC5-BE23-C94BD83B5EB6
P2860
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@ast
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@en
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@nl
type
label
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@ast
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@en
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@nl
altLabel
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@en
prefLabel
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@ast
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@en
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@nl
P2860
P356
P1476
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance
@en
P2093
Erwin Sablon
Fred Shapiro
P2860
P356
10.7150/IJMS.2.8
P407
P50
P577
2005-01-05T00:00:00Z